Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RANI Rani Therapeutics Holdings

Pre-Mkt 09-21 07:46:51 EDT

0.8620

+0.0104

+1.22%

盘前0.8500

-0.0120-1.39%

05:14 EDT

High0.8620	Low0.8202	Vol386.98K
Open0.8500	D1 Closing0.8516	Amplitude4.91%
Mkt Cap120.16M	Tradable Cap73.85M	Total Shares139.40M
T/O330.58K	T/O Rate0.45%	Tradable Shares85.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RANI","market":"US","secType":"STK","nameCN":"Rani Therapeutics Holdings","latestPrice":0.862,"timestamp":1789761600000,"preClose":0.8516,"halted":0,"volume":386984,"hourTrading":{"tag":"盘前","latestPrice":0.85,"preClose":0.862,"latestTime":"05:14 EDT","volume":801,"amount":681.192027,"timestamp":1789982087183,"change":-0.012,"changeRate":-0.013921,"amplitude":0.013225},"delay":0,"changeRate":0.012212306247064307,"floatShares":85674696,"shares":139395319,"eps":-0.217377,"marketStatus":"Pre-Mkt","change":0.0104,"latestTime":"09-21 07:46:51 EDT","open":0.85,"high":0.862,"low":0.8202,"amount":330577.9474296,"amplitude":0.049084,"askPrice":0.8887,"askSize":898,"bidPrice":0.7774,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.217377,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789997400000},"marketStatusCode":1,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.862,"preHourTrading":{"tag":"盘前","latestPrice":0.85,"preClose":0.862,"latestTime":"05:14 EDT","volume":801,"amount":681.192027,"timestamp":1789982087183,"change":-0.012,"changeRate":-0.013921,"amplitude":0.013225},"postHourTrading":{"tag":"盘后","latestPrice":0.844,"preClose":0.862,"latestTime":"19:30 EDT","volume":12203,"amount":10496.0756,"timestamp":1789774205083,"change":-0.018,"changeRate":-0.020882,"amplitude":0.020882},"volumeRatio":0.5488999278832933,"impliedVol":0.874,"impliedVolPercentile":0.228},"requestUrl":"/m/hq/s/RANI/wiki","defaultTab":"wiki","newsList":[{"id":"2665320935","title":"Rani Therapeutics Management to Attend Lake Street BIG10 Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320935","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320935?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:06","pubTimestamp":1788869169,"startTime":"0","endTime":"0","summary":"Rani Therapeutics management to attend Lake Street BIG10 growth conferenceRani Therapeutics management schedules investor meetings at Lake Street’s BIG10 conference on Sept. 10, 2026 in New York.A fir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLcfxhdq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014039.USD","LU0314104364.USD","BK4112","BCDF","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","BK4539","LU2210150020.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4007","SG9999014013.SGD","LU2095319765.USD","IE00BQXX3F31.USD","BK4588","RANI","BK4585","SG9999014005.SGD","NDAQ","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226346","title":"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Sanofi (OtherSNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226346?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rani Therapeutics Holdings (RANI) and Sanofi (SNYNF)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-and-sanofi-othersnynf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","SNYNF","BK4585","BK4007","XLV","BK4137","LABU","LU0029874061.USD","BK4588","RANI","BK4581","BK4539","XBI","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461110","title":"Chardan Initiates Rani Therapeutics Holdings at Buy With $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461110","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461110?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:06","pubTimestamp":1787051179,"startTime":"0","endTime":"0","summary":"Chardan Initiates Rani Therapeutics Holdings at Buy With $6 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129647","title":"Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129647?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:20","pubTimestamp":1786738826,"startTime":"0","endTime":"0","summary":"Emmaus Life Sciences Q2 revenue soars on licensing dealOverviewUS biopharmaceutical firm's Q2 revenue rose 124% yr/yr, driven by NIT license agreementCompany reduced operating expenses following sales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","EMMA","BK4539","RANI","BK4139","BK4007","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659312657","title":"Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2659312657","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659312657?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:29","pubTimestamp":1786735753,"startTime":"0","endTime":"0","summary":"Inflammation drug developer HCW Biologics' Q2 net loss widensOverviewUS biopharma firm's Q2 revenue rose yr/yr, driven by licensing agreement completionCompany posted higher Q2 net loss compared to pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","MGTX","HCWB","BK4539","VTGN","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659416751","title":"VistaGen Q1 Revenue Rises on Licensing Agreement Expiration","url":"https://stock-news.laohu8.com/highlight/detail?id=2659416751","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659416751?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:44","pubTimestamp":1786711464,"startTime":"0","endTime":"0","summary":"VistaGen Q1 revenue rises onlicensing agreement expirationOverviewUS biopharma firm's fiscal Q1 revenue rose, driven by licensing agreement expirationNet loss for fiscal Q1 narrowed from prior year as","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","RANI","BK4007","BK4139","BK4539","VTGN","DARE","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162468","title":"Rani Therapeutics Q2 FY26 Net Loss Narrows to USD 8.42 Million; Revenue Turns to USD 1.71 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162468","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162468?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651818,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Q2 FY26 net loss narrows to USD 8.42 million; revenue turns to USD 1.71 millionRani Therapeutics posted a Q2 net loss of USD 8.4 million, narrowing from USD 11.2 million a year earli","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLBssyl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659522162","title":"Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659522162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659522162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651502,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA4MLGG0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RANI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162345","title":"Rani Therapeutics Q2 Operating Expenses USD 10.536 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162345?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651502,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXRNXP6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RANI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893517","title":"Rani Therapeutics to Present at Canaccord Genuity Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893517?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:01","pubTimestamp":1786363276,"startTime":"0","endTime":"0","summary":"Rani Therapeutics to present at Canaccord Genuity Annual Growth ConferenceRani Therapeutics will participate in the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, 2026 in Boston.CEO Talat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL6T5RMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BN0W2W23.USD","BK4585","IE00BKPKM429.USD","NDAQ","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014039.USD","LU2210149790.SGD","BK4007","LU2210150020.SGD","RANI","BK4539","IE00BGHQF748.EUR","LU2095319765.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656855532","title":"Rani Therapeutics Names Michelle Gilson to Board as Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2656855532","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656855532?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:01","pubTimestamp":1785844916,"startTime":"0","endTime":"0","summary":"Rani Therapeutics names Michelle Gilson to board as audit committee chairRani Therapeutics named Michelle Gilson to its board, appointing her audit committee chair.Gilson was most recently CFO of Arce","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6rsJVq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999015952.SGD","IE00B3T34201.USD","LU0965508806.USD","LU2324357040.USD","BK4583","LU1430594728.SGD","LU0965509101.SGD","LU0965509283.SGD","LU1057294990.SGD","LU1934455863.HKD","BK4585","SG9999015978.USD","IE00B19Z3581.USD","LU0889565916.HKD","IBBQ","SG9999014021.USD","GILD","IE00B3QW5Z07.USD","TBXU","LU2468319806.SGD","LU0234570918.USD","SG9999014039.USD","LU0823416689.USD","RANI","IE00B64PRP62.GBP","NDAQ","LU0114720955.EUR","BK4566","LU0320765992.SGD","MEDI","BMED","LU0861579265.USD","LU1934455277.USD","IE00BN0W2T93.GBP","TMED","BK4139","LU1061106388.HKD","IBB","BCDF","IE00BN0W2W23.USD","SG9999015986.USD","IE00B19Z3B42.SGD","LU1674673691.USD","BIB","BBH","LU2112291526.USD","LU0289739699.SGD","IE00BKPKM429.USD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656744553","title":"Rani Therapeutics Appoints Michelle Gilson to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2656744553","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656744553?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:00","pubTimestamp":1785844809,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA43ZXPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RANI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655874890","title":"Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655874890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655874890?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:39","pubTimestamp":1785411548,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Nash from Canaccord Genuity reiterated a Buy rating on Rani Therapeutics Holdings, with a price target of $5.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-rani-therapeutics-holdings-rani-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-rani-therapeutics-holdings-rani-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RANI","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654511160","title":"Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2654511160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654511160?lang=en_us&edition=fundamental","pubTime":"2026-07-25 21:01","pubTimestamp":1784984465,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($SGMT)), (($PNC)), (($URI)), (($RANI)) and (($SCCO)). Here is a breakdown of their recent trades and t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/sagimet-pnc-united-rentals-rani-southern-copper-insider-shake-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/sagimet-pnc-united-rentals-rani-southern-copper-insider-shake-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","BK4535","URI","SETM","LU0971096721.USD","LU0052756011.USD","LU0742534661.SGD","BK4211","LU0314106906.USD","LU2106854487.HKD","LU0070302665.USD","BK4207","RANI","IAT","LU0251142724.SGD","LU0314104364.USD","SGMT","COPX","LU2463526074.USD","BK4139","BK4539","DBB","BK4504","BK4007","BK4588","LU0208291251.USD","PICK","LU0320765489.SGD","PNC","LU0310800965.SGD","LU0048573561.USD","LU0128525689.USD","LU0251131958.USD","BK4585","LU1506573853.SGD","LU1974910355.USD","BK4516","BK4566","LU1917777945.USD","LU2023250504.SGD","LU1721428933.USD","LU2023250843.SGD","LU1267930227.SGD","LU0170899867.USD","IE000M9KFDE8.USD","BK4104","LU1363072403.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653677002","title":"Top Insider Makes Bold Move on Rani Therapeutics Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2653677002","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653677002?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:03","pubTimestamp":1784858616,"startTime":"0","endTime":"0","summary":"New insider activity at Rani Therapeutics Holdings ( ($RANI) ) has taken place on July 23, 2026. Director Mir A. Imran has increased his stake in R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-bold-move-on-rani-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-bold-move-on-rani-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RANI","BK4539","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653773264","title":"Rani Therapeutics Director, 10% Owner Mir A. Imran Buys 36,000 Shares Worth $24,840","url":"https://stock-news.laohu8.com/highlight/detail?id=2653773264","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653773264?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:11","pubTimestamp":1784837460,"startTime":"0","endTime":"0","summary":"Rani Therapeutics director, 10% owner Mir A. Imran buys 36,000 shares worth $24,840Rani Therapeutics director Mir A Imran bought 36,000 Class A shares at $0.69, lifting his directly held stake to 2,11","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL7kNk5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rani Therapeutics Director, 10% Owner Mir A. Imran Buys 36,000 Shares Worth $24,840","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653789364","title":"Rani Therapeutics CEO Imran Talat Acquires 35,000 Shares Worth $25,193","url":"https://stock-news.laohu8.com/highlight/detail?id=2653789364","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653789364?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:29","pubTimestamp":1784672971,"startTime":"0","endTime":"0","summary":"Rani Therapeutics CEO Imran Talat acquires 35,000 shares worth $25,193Rani Therapeutics CEO Imran Talat bought 35,000 Class A common shares in an open-market purchase.Purchase price was USD 0.72 per s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL5MTZBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rani Therapeutics CEO Imran Talat Acquires 35,000 Shares Worth $25,193","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653524586","title":"Rani Therapeutics Grants CFO Nicholas Maestas Option for 2 Million Shares at $0.7 Exercise Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2653524586","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653524586?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:05","pubTimestamp":1784577926,"startTime":"0","endTime":"0","summary":"Rani Therapeutics grants CFO Nicholas Maestas option for 2 million shares at $0.7 exercise priceRani Therapeutics granted CFO Nicholas Maestas a stock option for 2 million Class A shares on July 17, 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL55rxQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4539","LU2095319765.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4007","IE00BN0W2V16.EUR","IE00BKPKM429.USD","SG9999014021.USD","BK4588","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","NDAQ","RANI","SG9999014013.SGD","BK4585","SG9999014039.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653243009","title":"Rani Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653243009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653243009?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:05","pubTimestamp":1784577901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA8CW3QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RANI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651044687","title":"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651044687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651044687?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:50","pubTimestamp":1784199034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rani Therapeutics Holdings (RANI), Urogen Pharma (UR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-urogen-pharma-urgn-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rani-therapeutics-holdings-rani-urogen-pharma-urgn-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4539","BK4588","XLV","XBI","LABU","LU0029874061.USD","RANI","BK4139","BK4007","BK4137","BK4585","VTVT","URGN","LU0128526141.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ranitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":-0.0596},{"period":"3month","weight":0.1017},{"period":"6month","weight":-0.2372},{"period":"1year","weight":0.7899},{"period":"ytd","weight":-0.3615}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1171}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.029107},{"month":2,"riseRate":1,"avgChangeRate":0.115354},{"month":3,"riseRate":0,"avgChangeRate":-0.24738},{"month":4,"riseRate":0.5,"avgChangeRate":0.262902},{"month":5,"riseRate":0.25,"avgChangeRate":-0.173805},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145137},{"month":7,"riseRate":0.8,"avgChangeRate":-0.013308},{"month":8,"riseRate":0.4,"avgChangeRate":-0.027096},{"month":9,"riseRate":0.4,"avgChangeRate":-0.137363},{"month":10,"riseRate":0.5,"avgChangeRate":0.74996},{"month":11,"riseRate":0.5,"avgChangeRate":-0.005763},{"month":12,"riseRate":0.25,"avgChangeRate":-0.022176}],"exchange":"NASDAQ","name":"Rani Therapeutics Holdings","nameEN":"Rani Therapeutics Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Rani Therapeutics Holdings(RANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Rani Therapeutics Holdings,RANI,Rani Therapeutics Holdings股票,Rani Therapeutics Holdings股票老虎,Rani Therapeutics Holdings股票老虎国际,Rani Therapeutics Holdings行情,Rani Therapeutics Holdings股票行情,Rani Therapeutics Holdings股价,Rani Therapeutics Holdings股市,Rani Therapeutics Holdings股票价格,Rani Therapeutics Holdings股票交易,Rani Therapeutics Holdings股票购买,Rani Therapeutics Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rani Therapeutics Holdings(RANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Rani Therapeutics Holdings(RANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}